Substance | Condition | Seq | Src | PMID | Dtl | Title |
Dihydroartemisinin | Esophageal Cancer | 4 | PM | 38111311 | 📋 | Dihydroartemisinin enhances the anti-tumour effect of photodynamic therapy by targeting PKM2-mediated glycolysis in oesophageal cancer cell |
Dihydroartemisinin | Esophageal Cancer | 3 | PM | 36506308 | 📋 | Network pharmacology- and molecular docking-based approaches to unveil the pharmacological mechanisms of dihydroartemisinin against esophageal carcinoma |
Dihydroartemisinin | Esophageal Cancer | 1 | PM | 34744749 | 📋 | Human Telomerase Reverse Transcriptase as a Therapeutic Target of Dihydroartemisinin for Esophageal Squamous Cancer |
Dihydroartemisinin | Esophageal Cancer | 2 | PM | 34655567 | 📋 | Dihydroartemisinin mediating PKM2-caspase-8/3-GSDME axis for pyroptosis in esophageal squamous cell carcinoma |
Dihydroartemisinin | Head and Neck Cancer | 2 | PM | 38515687 | 📋 | Regulation of Dihydroartemisinin on the pathological progression of laryngeal carcinoma through the periostin/YAP/IL-6 pathway |
Dihydroartemisinin | Head and Neck Cancer | 1 | PM | 34755560 | 📋 | Dihydroartemisinin inhibits IL-6-induced epithelial-mesenchymal transition in laryngeal squamous cell carcinoma via the miR-130b-3p/STAT3/β-catenin signaling pathway |
Dihydroartemisinin | Oral Cancer | 1 | PM | 34847839 | 📋 | Dihydroartemisinin represses oral squamous cell carcinoma progression through downregulating mitochondrial calcium uniporter |